{
    "2020-04-25": [
        [
            {
                "time": "",
                "original_text": "通策医疗一季度营收降5成净利润由盈转亏，股价却创新高，疑为基金抱团取暖",
                "features": {
                    "keywords": [
                        "通策医疗",
                        "一季度",
                        "营收下降",
                        "净利润亏损",
                        "股价创新高",
                        "基金抱团"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[东兴医药胡博新团队]通策医疗（600763）：公司发展模式稳健，2020Q1业绩受疫情拖累 盈利能力下降",
                "features": {
                    "keywords": [
                        "东兴医药",
                        "通策医疗",
                        "2020Q1",
                        "疫情影响",
                        "盈利能力下降",
                        "发展模式稳健"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}